首页 | 本学科首页   官方微博 | 高级检索  
     


Long-term follow-up of patients with congenital thrombotic thrombocytopenia purpura receiving a plasma-derived factor VIII (Koate) that contains ADAMTS13
Authors:Tammuella Chrisentery-Singleton  Lisa N. Boggio  Manuel D. Carcao  Sami Ibrahimi  Osman Khan  Arash Mahajerin  Anita Rajasekhar  Vivek Sharma  MacGregor Steele  Marcela Torres  Frank J. Rodino  Shannon L. Carpenter
Affiliation:1. American Thrombosis and Hemostasis Network, Rochester, New York, USA;2. Rush Hemophilia & Thrombophilia Center, Rush University Medical Center, Chicago, Illinois, USA;3. Division of Haematology/Oncology, Department of Paediatrics, The Hospital for Sick Children, Toronto, ON, Canada;4. OUHSC/Stephenson Cancer Center, Oklahoma City, Oklahoma, USA;5. University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA;6. Children's Hospital of Orange County, Orange, California, USA;7. University of Florida – Shands Hospital, Gainesville, Florida, USA;8. University of Louisville, Louisville, Kentucky, USA;9. Alberta Children's Hospital, Edmonton, AB, Canada;10. Department of Hematology, Cook Children's Medical Center, Fort Worth, Texas, USA;11. Churchill Outcomes Research, Red Bank, New Jersey, USA;12. Children's Mercy Hospital, Kansas City, Missouri, USA
Abstract:
Keywords:ADAMTS13 protein  congenital thrombotic thrombocytopenic  factor VIII/administration and dosage  microangiopathic haemolytic anaemia  paediatric  prophylaxis  purpura  Upshaw–Schulman syndrome  von Willebrand factor-cleaving protease
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号